Choosing Wisely in radiotherapy

Choosing Wisely in educating future African oncologists

Navigating evidence-based care with limited resources in Africa

Choosing Wisely in Tanzania

Choosing Wisely in multiple myeloma

Advocacy that impacts patient outcomes in Africa

Choosing Wisely in pathology

Participation of Africa to global randomised controlled clinical trials

Choosing Wisely campaigns in Africa

Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer

SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy

Raising awareness of the burden of cervical cancer in the Eastern Mediterranean region